Top Markets
Coin of the day
Neovacs S.A. Neovacs S.A.

Neovacs S.A.

ALNEV
Rang în acțiuni #21228
Neovacs S.A., a biotechnology company, focuses on the development of... Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for chronic autoimmune and inflammatory diseases using its proprietary Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of systemic lupus erythematosus; Phase IIa clinical trial for the treatment of dermatomyositis; and preclinical stage for the treatment of diabetes. It is also developing VEGF-Kinoid, which is in preclinical stage for the treatment of age-related macular degeneration and solid tumors; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company has a collaboration with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal and ovarian cancer. Neovacs S.A. was founded in 1993 and is based in Paris, France.
Preț acțiune
$0.00047446
Capitalizare de piață
$82.80
Schimbare (1 zi)
0.00%
Schimbare (1 an)
-98.16%
Țară
FR
Tranzacționează Neovacs S.A. (ALNEV)

Categorie

Istoric al prețului acțiunii pentru Neovacs S.A. (ALNEV)
Cel mai mare preț de închidere: $0.00 pe 2026-04-01

Cel mai mic preț de închidere: $55.15K pe 2010-04-01
Istoric al prețului acțiunii pentru Neovacs S.A. din 2010 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) 0.00%
2025 -99.78%
2024 592,903.23%
2023 -96.32%
2022 -99.92%
2021 -98.03%
2020 -37.62%
2019 -71.75%
2018 -62.61%
2017 -24.49%
2016 -11.42%
2015 -67.56%
2014 9.35%
2013 -13.08%
2012 -30.76%
2011 40.12%
2010 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$40.57 -35.48%
DK
$442.92 -8.84%
US
$754.58 37.38%
US
$309.11 96.60%
BE
$838.06 42.63%
NL